Standardization of Japanese cypress pollen antige
- Conditions
- Japanese cypress pollinosis
- Registration Number
- JPRN-jRCTs031220136
- Lead Sponsor
- Okano Mitsuhiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
1. Japanese adults having serum IgE specific for Japanese cypress pollen equal or above class 2
2. Aged equal or more than 20 years old and less than 60 years old
3. Regardless of gender
4. Acquisition of written informed consent for participation on this clinical trial
5. Possible to visit hospital/clinic and follow
1. Subjects using drugs such as antihistamine which may affect results of skin test at examination day
2. Subjects having disease on application site of skin test
3. Subjects having experience of Japanese cedar-specific allergen immunotherapy
4. Subjects having severe asthma
5. Subjects having uncontrolled allergic diseases
6. Subjects having experience of anaphylaxis
7. Subjects having experience of hypersensitivity to adrenalin
8. Subjects having heart, liver, kidney or blood diseases or infection which may affect the outcome of examination
9. Subjects with pregnancy or breastfeeding
10. Subjects who are judged inappropriate to participate in the trial by investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive reaction to skin tests
- Secondary Outcome Measures
Name Time Method Correlation with serum IgE titer, adverse reactions